Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

NCT01011205 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

893

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Advagraf
DRUG: Mycophenolate Mofetil
DRUG: Basiliximab
DRUG: Corticosteroids

Sponsor

Astellas Pharma Inc